Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) EBT Margin (2020 - 2025)

Journey Medical's EBT Margin history spans 6 years, with the latest figure at 8.07% for Q4 2025.

  • For the quarter ending Q4 2025, EBT Margin fell 2060.0% year-over-year to 8.07%, compared with a TTM value of 18.75% through Dec 2025, up 775.0%, and an annual FY2025 reading of 18.57%, up 793.0% over the prior year.
  • EBT Margin for Q4 2025 was 8.07% at Journey Medical, up from 13.6% in the prior quarter.
  • The five-year high for EBT Margin was 110.5% in Q3 2023, with the low at 99.99% in Q2 2021.
  • Average EBT Margin over 5 years is 32.69%, with a median of 27.95% recorded in 2025.
  • Year-over-year, EBT Margin soared 17299bps in 2023 and then plummeted -12684bps in 2024.
  • Tracing DERM's EBT Margin over 5 years: stood at 76.59% in 2021, then fell by -4bps to 79.97% in 2022, then soared by 83bps to 13.22% in 2023, then surged by 195bps to 12.54% in 2024, then plummeted by -164bps to 8.07% in 2025.
  • Per Business Quant, the three most recent readings for DERM's EBT Margin are 8.07% (Q4 2025), 13.6% (Q3 2025), and 24.89% (Q2 2025).